The record
| Class | bioregulator |
|---|---|
| Also known as | AEDP, Ala-Glu-Asp-Pro, brain cortex tetrapeptide |
| Chain length | 4 residues |
| Molecular weight | 430.41 Da |
| Half-life | - |
| Route | SC / oral (class) |
| Studied for | - |
| Research use | - |
| What has been shown | - |
| How it works | Khavinson tetrapeptide identified as a primary active component of Cortexin (bovine brain cortex peptide preparation); studied for neuroprotection and nerve repair. |
| Patent status | - |
| Regulatory status | - |
Blank = not established in the record. Nothing is estimated to fill a gap.
Where it is matched
- Nerve Support / Neuro-repair Environment (affection, 65%)
- Neuroprotection Signaling (affection, 37%)
- ADHD (illness, 30%)
- Alzheimer's disease (illness, 30%)
- Chronic inflammatory conditions (illness, 30%)
- Diabetic neuropathy (illness, 30%)
- Neuropathic pain (illness, 30%)
- Sarcoidosis-associated small fiber neuropathy (illness, 30%)
- Stroke recovery (illness, 30%)
- Traumatic brain injury (illness, 30%)
- Vascular dementia (illness, 30%)
- Low mood (symptom, 33%)
- Memory lapses (symptom, 50%)